Catalyst Wire Dossier Catalyst Wire Dossier

V920 (Vesicular Stomatitis Virus Ebola vaccine)

rVSV-EBOV vaccine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V920 (Vesicular Stomatitis Virus Ebola vaccine), covering 2019-07-12 to 2019-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002) [Phase 1]

See pricing